Avricore Health Inc.
AVCR.V
TSX
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -1,619.61% | -24,328.57% | -24,328.57% | -156.44% |
| Total Depreciation and Amortization | -- | -50.34% | -35.81% | -35.81% | -17.14% |
| Total Amortization of Deferred Charges | -- | 62.90% | 19.35% | 19.35% | -22.58% |
| Total Other Non-Cash Items | -- | 135.45% | 209.85% | 209.85% | 109.25% |
| Change in Net Operating Assets | -- | 103.05% | 96.36% | 96.36% | -116.60% |
| Cash from Operations | -- | -117.32% | -55.12% | -55.12% | -18.91% |
| Capital Expenditure | -- | 83.47% | 80.98% | 80.98% | 81.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 19.46% | 22.71% | 22.71% | -9.57% |
| Cash from Investing | -- | 79.43% | 78.35% | 78.35% | 78.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -74.67% | 321.69% | 321.69% | 132.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -56.14% | 610.00% | 610.00% | 10,240.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -164.76% | 239.84% | 239.84% | 823.31% |